Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Shortage reports
Actual shortage:
20 (3%)
Anticipated shortage:
6 (1%)
Avoided shortage:
88 (12%)
Resolved:
604 (84%)
718
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
89 (9%)
19 (73%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2019-04-03 | 2019-07-03 | 80441 |
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171501 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Avoided shortage | 2020-10-21 | 2020-11-10 | 126796 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2021-01-05 | 2021-12-22 | 130857 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Avoided shortage | 2020-07-02 | 2020-08-17 | 119319 |
| GD-AMLODIPINE/ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2017-07-24 | 2017-08-04 | 16832 |
| GD-AMLODIPINE/ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-01-22 | 2020-04-22 | 103957 |
| GD-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-11-17 | 2021-02-04 | 128484 |
| GD-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-12-16 | 2021-01-12 | 130219 |
| GD-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-08-04 | 2020-09-22 | 121654 |
| GD-LATANOPROST | 50MCG | SOLUTION | Resolved | 2022-03-15 | 2022-03-30 | 156728 |
| GD-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2023-01-17 | 2023-05-25 | 181289 |
| GD-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2022-11-29 | 2023-01-17 | 176221 |
| GD-LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-20 | 2019-09-18 | 91964 |
| GEN-CLOZAPINE | 200MG | TABLET | Resolved | 2017-03-23 | 2017-11-15 | 4063 |
| GEN-CLOZAPINE | 50MG | TABLET | Resolved | 2017-10-10 | 2017-10-21 | 24836 |
| GEN-CLOZAPINE | 100MG | TABLET | Avoided shortage | 2017-11-03 | 2017-11-23 | 28038 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2017-10-26 | 2018-08-23 | 27093 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-PRAVASTATIN | 40MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16032 |
| MYLAN-PRAVASTATIN | 20MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16148 |
| MYLAN-PREGABALIN | 25MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51561 |
| MYLAN-PREGABALIN | 50MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51567 |
| MYLAN-PREGABALIN | 75MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51573 |
| MYLAN-PREGABALIN | 150MG | CAPSULE | Discontinued | 2018-06-05 | 2018-08-01 | 51582 |
| MYLAN-PREGABALIN | 300MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51588 |
| MYLAN-QUETIAPINE | 25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6778 |
| MYLAN-QUETIAPINE | 100MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6781 |
| MYLAN-QUETIAPINE | 200MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6784 |
| MYLAN-QUETIAPINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6788 |
| MYLAN-RABEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16039 |
| MYLAN-RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16042 |
| MYLAN-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6792 |
| MYLAN-RAMIPRIL | 2.5MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6797 |
| MYLAN-RAMIPRIL | 5.0MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6801 |
| MYLAN-RAMIPRIL | 10MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6805 |
| MYLAN-RANITIDINE | 150MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6808 |
| MYLAN-RANITIDINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6811 |
| MYLAN-RISEDRONATE | 150MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16049 |